Scott Schoenhaus Analyst Performance

Equity Research at KeyCorp

Scott Schoenhaus is a stock analyst at KeyCorp focused in the medical sector, covering 15 publicly traded companies. Over the past year, Scott Schoenhaus has issued 20 stock ratings, including buy and hold recommendations. While full access to Scott Schoenhaus' proprietary MarketBeat Analyst Rating is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Scott Schoenhaus' coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rating: Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeat
Average Return: 00.00% 12-Month ROI
Success Rate: 00.00% Profitable Ratings
Total Ratings: 22 Last 5 Years
Buy Recommendations: 81.82% 18 Buy Ratings
Companies Covered: 15 Unique Companies

Ratings Distribution

Rating	Percentage	Count
Strong Buy	0.0%	0 ratings
Buy	81.8%	18 ratings
Hold	18.2%	4 ratings
Sell	0.0%	0 ratings

Out of 22 total stock ratings issued by Scott Schoenhaus at KeyCorp, the majority (81.8%) have been Buy recommendations, followed by 18.2% Hold.

Best & Worst Calls

Best Call
000.0%
VEEV
Aug 2020
Subscribe to MarketBeat All Access to get analyst recommendation ROI.

Exchange Coverage

Exchange	Percentage	Count
NASDAQ	60.0% of companies on NASDAQ	9 companies
NYSE	40.0% of companies on NYSE	6 companies

Scott Schoenhaus, an analyst at KeyCorp, currently covers 15 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.

Coverage Focus

Sector Icon	Sector	Percentage
	Medical 11 companies	73.3%
	Basic Materials 2 companies	13.3%
	Computer and Technology 2 companies	13.3%

Scott Schoenhaus of KeyCorp specializes in stock coverage within the Medical sector, with additional focus on Basic Materials and Computer and Technology companies.

Coverage Industries

Industry	Percentage
MEDICAL INFO SYS 4 companies	26.7%
MEDICAL SERVICES 3 companies	20.0%
MED - BIOMED/GENE 3 companies	20.0%
CHEM - DIVERSIFD 2 companies	13.3%
COMP - SOFTWARE 1 company	6.7%
CUSTOM COMPUTER PROGRAMMING SERVICES 1 company	6.7%
INTERNET SOFTWARE 1 company	6.7%

About Scott Schoenhaus

Scott Schoenhaus is a Managing Director and Equity Research Analyst for KeyBanc Capital Markets Inc. With the firm since May 2022, he focuses on researching healthcare IT (HCIT) companies. Prior to joining KeyBanc Capital Markets, Scott had been at Stephens Inc. for eight years, where he most recently served as a Managing Director and Senior Analyst on HCIT research coverage. Scott started his career in equity research as an Industrials Research Associate at Wolfe Research (airlines, freight & transportation) in 2011. In total, Scott has 15 years of experience in the financial industry, which includes work experience at Sanford Bernstein and Mezz Cap. Scott earned an Bachelor’s degree in economics from Georgetown University. He also holds the Series 7, 63, 86 & 87 industry licenses.

Follow on LinkedIn

Timeframe

Start Date

End Date

Rating

12-Month ROIAll ROI

Export to Excel

Company	Report Date	Action	Report Date Price	12-Month Price Target	Rating
LFMD LifeMD	8/6/2025	Lower Price Target	$6.79	$12.00	Overweight
ALB Albemarle	7/30/2025	Reiterated Rating	$71.63		Sector Weight
SLP Simulations Plus	7/15/2025	Downgrade	$17.47		Sector Weight
CERT Certara	7/14/2025	Lower Price Target	$11.09	$15.00	Overweight
ALB Albemarle	7/14/2025	Lower Price Target	$71.07	$87.00	Overweight
ABCL AbCellera Biologics	7/14/2025	Boost Price Target	$4.01	$10.00	Overweight
EMN Eastman Chemical	7/14/2025	Lower Price Target	$80.29	$93.00	Overweight
DOCS Doximity	7/14/2025	Boost Price Target	$60.26	$70.00	Overweight
SLP Simulations Plus	7/14/2025	Downgrade	$16.96	$25.00	Sector Weight
HNGE Hinge Health	6/16/2025	Initiated Coverage	$34.76	$45.00	Overweight
ODD ODDITY Tech	4/16/2025	Lower Price Target	$41.08	$50.00	Overweight
HQY HealthEquity	4/16/2025	Lower Price Target	$83.03	$100.00	Overweight
CERT Certara	4/16/2025	Boost Price Target	$13.88	$18.00	Overweight
ABSI Absci	4/16/2025	Boost Price Target	$3.12	$9.00	Overweight
ABCL AbCellera Biologics	4/16/2025	Boost Price Target	$2.43	$5.00	Overweight
SLP Simulations Plus	4/16/2025	Boost Price Target	$32.81	$40.00	Overweight
SDGR Schrodinger	4/16/2025	Boost Price Target	$25.59	$32.00	Overweight
PHR Phreesia	4/16/2025	Lower Price Target	$23.89	$28.00	Overweight
HQY HealthEquity	3/24/2025	Lower Price Target	$84.88	$110.00	Overweight
SDGR Schrodinger	1/24/2025	Boost Price Target	$24.91	$27.00	Overweight

Stock Forecasts and Research Tools

Today's Ratings

Top-Rated Stocks

More Ratings Tools

Price Forecasts for Popular Stocks

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.